tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Compare Lepu Biopharma Co. Ltd. Class H (2157) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$10.69B
30.77
39.33%
Ascletis Pharma, Inc.
HK$17.31
HK$18.57B
-9.33
200.00%
2 Buy
1 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$20.86B
-25.84
63.58%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.87B
-77.24
63.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$23.28B
42.36
403.26%
1 Buy
0 Hold
0 Sell
Moderate Buy
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$4.39B
-8.57
6.48%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.81
1.69
41.02%
HK:1672
Ascletis Pharma, Inc.
17.31
11.06
176.96%
HK:2162
Keymed Biosciences, Inc.
74.10
29.80
67.27%
HK:2171
CARsgen Therapeutics Holdings Ltd.
20.90
8.20
64.57%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
61.80
49.82
415.86%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
5.75
0.15
2.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts